Latest Exploration News

Omega Oil and Gas has secured a significant 19.43% equity interest in Elixir Energy, deepening its footprint in Queensland’s Taroom Trough and gaining exposure to near-term drilling catalysts.

Omega Oil and Gas has secured a significant 19.43% equity interest in Elixir Energy, strengthening its foothold in Queensland’s Taroom Trough ahead of key drilling activities in 2026.

Elixir Energy secures $16.6 million in a capital raise led by Omega Oil and Gas, unlocking Phase-2 of its strategic plan to define reserves in Queensland’s Taroom Trough. This funding accelerates appraisal drilling and production testing, positioning Elixir for a pivotal year ahead.

Warriedar Resources has officially been acquired by Capricorn Metals through a court-approved scheme, with shareholders exchanging their holdings for Capricorn shares and options. The takeover culminates in Warriedar’s imminent delisting from the ASX.

Warriedar Resources has completed its acquisition by Capricorn Metals through a court-approved scheme, with shareholders exchanging their shares for Capricorn stock. The takeover triggers Warriedar’s removal from the ASX next week.

Legacy Minerals reports significant progress across its exploration portfolio, with Earth AI completing a major earn-in at Fontenoy and Rio Tinto gearing up for a deep geophysical survey at Thomson. Ongoing drilling and partner commitments highlight the company’s potential for new discoveries.

Trigg Minerals has revealed a significant northern extension of high-grade antimony mineralisation at its Antimony Canyon Project in Utah, confirming bonanza-grade continuity and validating its exploration model.

Mount Ridley Mines has identified seven new high-priority rare earth and gallium target zones forming a 33km untested corridor near existing resources in Western Australia, setting the stage for significant exploration expansion.

Adelong Gold Limited refutes claims by Great Divide Mining of a binding agreement to resolve their Challenger Mines joint venture dispute, leaving the matter unsettled and market watchers cautious.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Tartana Minerals has secured a $1.275 million placement priced at a 17% premium, including significant director participation pending shareholder approval. The capital raise aims to strengthen working capital and retire convertible notes, supporting advancement of its Chillagoe assets.

Narryer Metals has outlined a substantial Exploration Target for its Rocky Gully Project in Western Australia, highlighting promising grades of scandium, rare earth elements, gallium, and potential titanium co-products. The company is gearing up for a new drilling campaign aimed at defining a maiden resource.